Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Leukemia, Myeloid, Acute 17Myelodysplastic Syndromes 14Precursor Cell Lymphoblastic Leukemia-Lymphoma 13Leukemia, Biphenotypic, Acute 10Leukemia, Myelomonocytic, Chronic 9Hematologic Neoplasms 8Hodgkin Disease 6Myeloproliferative Disorders 5Lymphoma, Non-Hodgkin 5Leukemia, Myelogenous, Chronic, BCR-ABL Positive 5Lymphoma, T-Cell 3Lymphoma, Follicular 3Leukemia, Lymphocytic, Chronic, B-Cell 3Graft vs Host Disease 3Burkitt Lymphoma 3Anemia, Refractory, with Excess of Blasts 3Primary Myelofibrosis 2Multiple Myeloma 2Lymphoma, Mantle-Cell 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma, B-Cell, Marginal Zone 2Lymphoma 2Leukemia, Prolymphocytic 2Leukemia, Myeloid 2Leukemia, Monocytic, Acute 2Leukemia, Lymphoid 2Blastic Plasmacytoid Dendritic Cell Neoplasm 2Thrombocythemia, Essential 1Sarcoma, Ewing 1Rhabdomyosarcoma 1

Interventions

Standard of Care 3Practice Guidelines as Topic 3Interviews as Topic 2fludarabine 1Whole-Body Irradiation 1Watchful Waiting 1Telemedicine 1Tacrolimus 1Stem Cell Transplantation 1Rituximab 1Palliative Care 1Observation 1Mycophenolic Acid 1Methods 1Melphalan 1Granulocyte Colony-Stimulating Factor 1Geriatric Assessment 1Filgrastim 1Educational Status 1Early Intervention, Educational 1Cyclophosphamide 1Counseling 1CT-P10 1Bendamustine Hydrochloride 1Behavior Therapy 1Absorptiometry, Photon 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Hematopoietic and Lymphoid System Neoplasm × Whole-Body Irradiation × Clear all
NCT04022239 2026-01-12

Bendamustine With or Without Cyclophosphamide in Preventing GVHD in Patients Undergoing Stem Cell Transplant

M.D. Anderson Cancer Center

Phase 1/2 Recruiting
25 enrolled

Hematopoietic and Lymphoid System Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon âš¡